<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32814898</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>585</Volume><Issue>7823</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>C9orf72 in myeloid cells suppresses STING-induced inflammation.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>101</EndPage><MedlinePgn>96-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-020-2625-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative disorders that overlap in their clinical presentation, pathology and genetic origin. Autoimmune disorders are also overrepresented in both ALS and FTD, but this remains an unexplained epidemiologic observation<sup>1-3</sup>. Expansions of a hexanucleotide repeat (GGGGCC) in the C9orf72 gene are the most common cause of familial ALS and FTD (C9-ALS/FTD), and lead to both repeat-containing RNA and dipeptide accumulation, coupled with decreased C9orf72 protein expression in brain and peripheral blood cells<sup>4-6</sup>. Here we show in mice that loss of C9orf72 from myeloid cells alone is sufficient to recapitulate the age-dependent lymphoid hypertrophy and autoinflammation seen in animals with a complete knockout of C9orf72. Dendritic cells isolated from C9orf72<sup>-/-</sup> mice show marked early activation of the type I interferon response, and C9orf72<sup>-/-</sup> myeloid cells are selectively hyperresponsive to activators of the stimulator of interferon genes (STING) protein-a key regulator of the innate immune response to cytosolic DNA. Degradation of STING through the autolysosomal pathway is diminished in C9orf72<sup>-/-</sup> myeloid cells, and blocking STING suppresses hyperactive type I interferon responses in C9orf72<sup>-/-</sup> immune cells as well as splenomegaly and inflammation in C9orf72<sup>-/-</sup> mice. Moreover, mice lacking one or both copies of C9orf72 are more susceptible to experimental autoimmune encephalitis, mirroring the susceptibility to autoimmune diseases seen in people with C9-ALS/FTD. Finally, blood-derived macrophages, whole blood and brain tissue from patients with C9-ALS/FTD all show an elevated type I interferon signature compared with samples from people with sporadic ALS/FTD; this increased interferon response can be suppressed with a STING inhibitor. Collectively, our results suggest that patients with C9-ALS/FTD have an altered immunophenotype because their reduced levels of C9orf72 cannot suppress the inflammation mediated by the induction of type I interferons by STING.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCauley</LastName><ForeName>Madelyn E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Rourke</LastName><ForeName>Jacqueline Gire</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#xe1;&#xf1;ez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7719-1963</Identifier><AffiliationInfo><Affiliation>Departament de Microbiologia i Ecologia, Universitat de Val&#xe8;ncia, Burjassot, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina, Universitat de Val&#xe8;ncia, Burjassot, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markman</LastName><ForeName>Janet L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ritchie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1496-4436</Identifier><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinchen</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5198-6581</Identifier><AffiliationInfo><Affiliation>Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lall</LastName><ForeName>Deepti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Mengyao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhammad</LastName><ForeName>A K M G</ForeName><Initials>AKMG</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Shaughn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landeros</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arditi</LastName><ForeName>Moshe</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9042-2909</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferies</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baloh</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><Identifier Source="ORCID">0000-0002-0100-8376</Identifier><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. robert.baloh@csmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. robert.baloh@csmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. robert.baloh@csmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS097545</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM118288</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R21AI126368-01</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS069669</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI126368</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS069669</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606498">C9orf72 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C530855">Sting1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2020 Sep;585(7823):34-35</RefSource><PMID Version="1">32814910</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004681" MajorTopicYN="N">Encephalomyelitis, Autoimmune, Experimental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022423" MajorTopicYN="N">Myeloid Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32814898</ArticleId><ArticleId IdType="mid">NIHMS1610184</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pii">10.1038/s41586-020-2625-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K &amp; Goldacre MJ Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81, 1222&#x2013;1225, doi:10.1212/WNL.0b013e3182a6cc13 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease. Journal of neurology, neurosurgery, and psychiatry 84, 956&#x2013;962, doi:10.1136/jnnp-2012-304644 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304644</ArticleId><ArticleId IdType="pmc">PMC3840954</ArticleId><ArticleId IdType="pubmed">23543794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA et al. Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture. Neurology(R) neuroimmunology &amp; neuroinflammation 3, e301, doi:10.1212/NXI.0000000000000301 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000301</ArticleId><ArticleId IdType="pmc">PMC5087253</ArticleId><ArticleId IdType="pubmed">27844039</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256, doi:10.1016/j.neuron.2011.09.011 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268, doi:10.1016/j.neuron.2011.09.010 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol 126, 895&#x2013;905, doi:10.1007/s00401-013-1199-1 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329, doi:10.1126/science.aaf1064 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Scientific reports 6, 23204, doi:10.1038/srep23204 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Science translational medicine 8, 347ra393, doi:10.1126/scitranslmed.aaf6038 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly D, Haak S, Sisirak V &amp; Reizis B The role of dendritic cells in autoimmunity. Nat Rev Immunol 13, 566&#x2013;577, doi:10.1038/nri3477 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3477</ArticleId><ArticleId IdType="pmc">PMC4160805</ArticleId><ArticleId IdType="pubmed">23827956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner A &amp; Ruffell B Dendritic Cells and Cancer Immunity. Trends Immunol 37, 855&#x2013;865, doi:10.1016/j.it.2016.09.006 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2016.09.006</ArticleId><ArticleId IdType="pmc">PMC5135568</ArticleId><ArticleId IdType="pubmed">27793569</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol 78, 426&#x2013;438, doi:10.1002/ana.24453 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Abram CL, Roberge GL, Hu Y &amp; Lowell CA Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice. Journal of immunological methods 408, 89&#x2013;100, doi:10.1016/j.jim.2014.05.009 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2014.05.009</ArticleId><ArticleId IdType="pmc">PMC4105345</ArticleId><ArticleId IdType="pubmed">24857755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51, 226&#x2013;235, doi:10.1016/j.molcel.2013.05.022 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.05.022</ArticleId><ArticleId IdType="pmc">PMC3808999</ArticleId><ArticleId IdType="pubmed">23747010</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H, Konno K &amp; Barber GN Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155, 688&#x2013;698, doi:10.1016/j.cell.2013.09.049 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.09.049</ArticleId><ArticleId IdType="pmc">PMC3881181</ArticleId><ArticleId IdType="pubmed">24119841</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonugunta VK et al. Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and Can Be Targeted to Enhance Anti-tumor Response. Cell reports 21, 3234&#x2013;3242, doi:10.1016/j.celrep.2017.11.061 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.11.061</ArticleId><ArticleId IdType="pmc">PMC5905341</ArticleId><ArticleId IdType="pubmed">29241549</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran T et al. Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. The EMBO journal 37, doi:10.15252/embj.201797858 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797858</ArticleId><ArticleId IdType="pmc">PMC5897779</ArticleId><ArticleId IdType="pubmed">29496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Woehlbier U &amp; Manque PA The Enigmatic Role of C9ORF72 in Autophagy. Front Neurosci 11, 442, doi:10.3389/fnins.2017.00442 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00442</ArticleId><ArticleId IdType="pmc">PMC5541066</ArticleId><ArticleId IdType="pubmed">28824365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262&#x2013;266, doi:10.1038/s41586-019-1006-9 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1006-9</ArticleId><ArticleId IdType="pubmed">30842662</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag SM et al. Targeting STING with covalent small-molecule inhibitors. Nature 559, 269&#x2013;273, doi:10.1038/s41586-018-0287-8 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0287-8</ArticleId><ArticleId IdType="pubmed">29973723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S et al. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proceedings of the National Academy of Sciences of the United States of America 112, E710&#x2013;717, doi:10.1073/pnas.1420217112 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1420217112</ArticleId><ArticleId IdType="pmc">PMC4343138</ArticleId><ArticleId IdType="pubmed">25646421</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine W et al. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proceedings of the National Academy of Sciences of the United States of America 115, E11523&#x2013;E11531, doi:10.1073/pnas.1814753115 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814753115</ArticleId><ArticleId IdType="pmc">PMC6298088</ArticleId><ArticleId IdType="pubmed">30442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber JP &amp; Farrar JD Regulation of effector and memory T-cell functions by type I interferon. Immunology 132, 466&#x2013;474, doi:10.1111/j.1365-2567.2011.03412.x (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2011.03412.x</ArticleId><ArticleId IdType="pmc">PMC3075500</ArticleId><ArticleId IdType="pubmed">21320124</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall A et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120&#x2013;131, doi:10.1016/j.immuni.2011.11.018 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.11.018</ArticleId><ArticleId IdType="pmc">PMC3269499</ArticleId><ArticleId IdType="pubmed">22284419</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor RA et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. Journal of immunology 181, 3750&#x2013;3754, doi:10.4049/jimmunol.181.6.3750 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.6.3750</ArticleId><ArticleId IdType="pmc">PMC2619513</ArticleId><ArticleId IdType="pubmed">18768826</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail A et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. Journal of neurology, neurosurgery, and psychiatry 84, 79&#x2013;87, doi:10.1136/jnnp-2012-303326 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303326</ArticleId><ArticleId IdType="pubmed">23085936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemos H et al. Activation of the STING adaptor attenuates experimental autoimmune encephalitis. Journal of immunology 192, 5571&#x2013;5578, doi:10.4049/jimmunol.1303258 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303258</ArticleId><ArticleId IdType="pmc">PMC4086255</ArticleId><ArticleId IdType="pubmed">24799564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB et al. Population-based risks for cancer in patients with ALS. Neurology 87, 289&#x2013;294, doi:10.1212/WNL.0000000000002757 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002757</ArticleId><ArticleId IdType="pmc">PMC4955272</ArticleId><ArticleId IdType="pubmed">27170569</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo SR et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830&#x2013;842, doi:10.1016/j.immuni.2014.10.017 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.10.017</ArticleId><ArticleId IdType="pmc">PMC4384884</ArticleId><ArticleId IdType="pubmed">25517615</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci 18, 1175&#x2013;1182, doi:10.1038/nn.4065 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter DA et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258&#x2013;262, doi:10.1038/s41586-018-0448-9 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0448-9</ArticleId><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y et al. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. The Journal of experimental medicine 214, 1493&#x2013;1507, doi:10.1084/jem.20161524 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161524</ArticleId><ArticleId IdType="pmc">PMC5413337</ArticleId><ArticleId IdType="pubmed">28356390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>